Evidence map›Paper›PMID 31215220›Full record

ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Influence of Interleukin-6 (IL-6) Promoter Gene Polymorphisms (-174G>C, -572G>C, and -597G>A) on IL-6 Plasma Levels and Their Impact in the Development of Acute Ischemic Stroke in Young Indians.

Mohammad Suhail Akhter, Arijit Biswas, Saleh Mohammed Abdullah, Yahya Hobani, Ravi Ranjan, Madhuri Behari, Renu Saxena

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Association of theBiology of sport · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Promoter polymorphism ofBiomedical reports · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Mohammad Suhail Akhter1 Department of Hematology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Arijit Biswas3 Institute of Experimental Hematology and Transfusion Medicine, Sigmund Freud, Germany.
Saleh Mohammed Abdullah2 Applied Medical Sciences, Jazan University, Jazan University, Jazan, Saudi Arabia.
Yahya Hobani2 Applied Medical Sciences, Jazan University, Jazan University, Jazan, Saudi Arabia.
Ravi Ranjan1 Department of Hematology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Madhuri Behari1 Department of Hematology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Renu Saxena1 Department of Hematology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
All India Institute of Medical Sciences · INJazan University · SASigmund Freud Institut · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to determine whether there is an influence of interleukin 6 (

Indexed as

AdolescentAdultBrain IschemiaCase-Control StudiesFemaleHumansIndiaInterleukin-6MaleMiddle AgedPolymorphism, GeneticPolymorphism, Single NucleotidePromoter Regions, GeneticStrokeYoung AdultInterleukin-6IL-6 plasma levelsIL-6 promoter polymorphismsyoung ischemic stroke

Identifiers

PMID31215220
PMCPMC6714995
OpenAlexW2949643066

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.